Update on the metabolic syndrome in children

Jeffrey M Saland1

  • 1Department of Pediatrics, The Mount Sinai School of Medicine, New York, NY 10029, USA. jeff.saland@mssm.edu

Insights

Metabolic syndrome is increasingly diagnosed in children, primarily affecting those who are overweight or obese. Early intervention strategies are crucial for preventing and treating this condition and its associated cardiovascular risks.

Area of Science:

  • Pediatrics
  • Metabolic Disorders
  • Cardiovascular Health

Background:

  • Metabolic syndrome is a growing concern in pediatric populations.
  • It is strongly linked to overweight and obesity in children.
  • The condition is associated with early signs of atherosclerosis.

Purpose of the Study:

  • To provide an updated review of pediatric metabolic syndrome.
  • To highlight the prevalence and risk factors in children.
  • To emphasize the need for intervention strategies.

Main Methods:

  • Review of current epidemiological data on childhood metabolic syndrome.
  • Analysis of factors contributing to the development of metabolic syndrome in youth.
  • Synthesis of information on associated cardiovascular risk factors.

Main Results:

  • Metabolic syndrome is increasingly identified in children, predominantly in those who are overweight or obese.
  • Atherosclerosis is a significant comorbidity.
  • Cardiovascular risk factors are influenced by genetics, prenatal/infantile factors, lifestyle, and socioeconomic status.

Conclusions:

  • Epidemiological data on pediatric metabolic syndrome are now robust.
  • Systematic approaches for prevention and treatment are urgently needed.
  • Addressing metabolic syndrome in childhood is critical for long-term health outcomes.
Abstract

Related Concept Videos

Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...